Structure guided generation of thieno[3, 2-d]pyrimidin-4-amine Mycobacterium tuberculosis bd oxidase inhibitors. Issue 1 (12th January 2021)
- Record Type:
- Journal Article
- Title:
- Structure guided generation of thieno[3, 2-d]pyrimidin-4-amine Mycobacterium tuberculosis bd oxidase inhibitors. Issue 1 (12th January 2021)
- Main Title:
- Structure guided generation of thieno[3, 2-d]pyrimidin-4-amine Mycobacterium tuberculosis bd oxidase inhibitors
- Authors:
- Hopfner, Sarah M.
Lee, Bei Shi
Kalia, Nitin P.
Miller, Marvin J.
Pethe, Kevin
Moraski, Garrett C. - Abstract:
- Abstract : Screening for inhibitors of Cyt- bd in Mycobacterium bovis BCG and Mycobacterium tuberculosis revealed thieno[3, 2- d ]pyrimidine (7 ) which through SAR efforts resulted in an improved analogue (19 ) of this scaffold. Abstract : Cytochrome bd oxidase (Cyt- bd ) is an attractive drug target in Mycobacterium tuberculosis, especially in the context of developing a drug combination targeting energy metabolism. However, currently few synthetically assessable scaffolds target Cyt- bd . Herein, we report that thieno[3, 2- d ]pyrimidin-4-amines inhibit Cyt- bd, and report an initial structure–activity-relationship (SAR) of 13 compounds in three mycobacterial strains: Mycobacterium bovis BCG, Mycobacterium tuberculosis H37Rv and Mycobacterium tuberculosis clinical isolate N0145 in an established ATP depletion assay with or without the cytochrome bcc : aa 3 (QcrB) inhibitor Q203. All compounds displayed activity against M. bovis BCG and the M. tuberculosis clinical isolate strain N0145 with ATP IC50 values from 6 to 54 μM in the presence of Q203 only, as expected from a Cyt- bd inhibitor. All derivatives were much less potent against M. tuberculosis H37Rv compared to N0145 (IC50 's from 24 to >100 μM and 9–52 μM, respectively), an observation that may be attributed to the higher expression of the Cyt- bd -encoding genes in the laboratory-adapted M. tuberculosis H37Rv strain. N -(4-( tert -butyl)phenethyl)thieno[3, 2- d ]pyrimidin-4-amine (19 ) was the most active compoundAbstract : Screening for inhibitors of Cyt- bd in Mycobacterium bovis BCG and Mycobacterium tuberculosis revealed thieno[3, 2- d ]pyrimidine (7 ) which through SAR efforts resulted in an improved analogue (19 ) of this scaffold. Abstract : Cytochrome bd oxidase (Cyt- bd ) is an attractive drug target in Mycobacterium tuberculosis, especially in the context of developing a drug combination targeting energy metabolism. However, currently few synthetically assessable scaffolds target Cyt- bd . Herein, we report that thieno[3, 2- d ]pyrimidin-4-amines inhibit Cyt- bd, and report an initial structure–activity-relationship (SAR) of 13 compounds in three mycobacterial strains: Mycobacterium bovis BCG, Mycobacterium tuberculosis H37Rv and Mycobacterium tuberculosis clinical isolate N0145 in an established ATP depletion assay with or without the cytochrome bcc : aa 3 (QcrB) inhibitor Q203. All compounds displayed activity against M. bovis BCG and the M. tuberculosis clinical isolate strain N0145 with ATP IC50 values from 6 to 54 μM in the presence of Q203 only, as expected from a Cyt- bd inhibitor. All derivatives were much less potent against M. tuberculosis H37Rv compared to N0145 (IC50 's from 24 to >100 μM and 9–52 μM, respectively), an observation that may be attributed to the higher expression of the Cyt- bd -encoding genes in the laboratory-adapted M. tuberculosis H37Rv strain. N -(4-( tert -butyl)phenethyl)thieno[3, 2- d ]pyrimidin-4-amine (19 ) was the most active compound with ATP IC50 values from 6 to 18 μM against all strains in the presence of Q203, making it a good chemical probe for interrogation the function of the mycobacterial Cyt- bd under various physiological conditions. … (more)
- Is Part Of:
- RSC medicinal chemistry. Volume 12:Issue 1(2021)
- Journal:
- RSC medicinal chemistry
- Issue:
- Volume 12:Issue 1(2021)
- Issue Display:
- Volume 12, Issue 1 (2021)
- Year:
- 2021
- Volume:
- 12
- Issue:
- 1
- Issue Sort Value:
- 2021-0012-0001-0000
- Page Start:
- 73
- Page End:
- 77
- Publication Date:
- 2021-01-12
- Subjects:
- Pharmaceutical chemistry -- Periodicals
615.19005 - Journal URLs:
- http://www.rsc.org/ ↗
https://www.rsc.org/journals-books-databases/about-journals/rsc-medicinal-chemistry ↗ - DOI:
- 10.1039/d0md00398k ↗
- Languages:
- English
- ISSNs:
- 2632-8682
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8036.751550
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15817.xml